The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 9 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Kluz: Unique tech without paying customers is a project, not a business
“If I don't see evidence that people are paying you money consistently and repeatedly, right? I'm going to have a hard time believing that you're doing something That maybe you're doing something no one else can do, but if no one's paying you for it, that's not…”
Kluz: Niterra Ventures does not require business unit alignment for deals
“So because our job is to drive new core assets which are effectively non-core, we don't need business unit alignment. But we do need a there on how is this going to create a new revenue stream for Natera in the future.”
Kluz: 3:1 LTV-to-CAC ratio is the diligence sweet spot
“I think three to one LTV to CAC seems to be kind of a sweet spot. I, that's kind of sometimes aspirational. A few of our portfolio companies have seen six to one, which is, I think outstanding. But that's the general sort of benchmark that we look for.”
Kluz: Niterra evaluates authentication startup to combat counterfeit spark plugs
“I'm actually working on an authentication play right now. So there's a company that's in the authentication space, right? So authenticating so it's real-time visibility of product. And making sure that it's authentic, right? And making sure it was manufactured…”
Kluz: Career investors often forget founders have businesses to run
“I think when, you know, investors, sometimes life, lifetime investors never been on the operational side, I've noticed tend to kind of lose sight what the operator's kind of going through, right? The operator has, You know, day to day responsibility for the bu…”
Kluz: Niterra Ventures invested in cold plasma startup Neoplast Med
“So we invested in a company called neoplast medical, which is a cold plasma based medical device uses inert gases to produce cold plasma and sanitizes wounds and reduces healing time”
Kluz: Niterra Ventures invested in synthetic skin startup Imbed Biosciences
“And then kind of connected to that, we invested in another company in the advanced wound care space called Embed Biosciences. That's a synthetic skin that gets applied to wounds. It's really interesting. The FDA approved for two indications.”